ANISH BHATNAGAR (President and CEO) sold 2.9% of their position (21.09K shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $965.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/6/2025ACC: 0001415889-25-000953
DirectorOfficer· President and CEO
Since Jan 2019
-21.09K
Net shares
Net seller
$965.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
21.09K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−10.08K
Price / share
$45.37
Trade value
$457.15K
% of position
1.4%
1/2/2025
719.55K→709.48K
Common Stock
Direct
Shares
−860.00
Price / share
$45.92
Trade value
$39.49K
% of position
0.1%
1/2/2025
709.48K→708.62K
Common Stock
Direct
Shares
−10.15K
Price / share
$46.18
Trade value
$468.88K
% of position
1.4%
1/3/2025
708.62K→698.46K
Total
Net shares
−21.09K
Net value
-$965.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | S · Sale | −10.08K | $45.37 | $457.15K | 1.4% | 719.55K | 709.48K |
| Common Stock Direct | 1/2/2025 | S · Sale | −860.00 | $45.92 | $39.49K | 0.1% | 709.48K | 708.62K |
| Common Stock Direct | 1/3/2025 | S · Sale | −10.15K | $46.18 | $468.88K | 1.4% | 708.62K | 698.46K |
| Total | −21.09K | -$965.52K | ||||||
Derivative Transactions0
No derivative transactions reported